Prolgolimab Antibody
BCD-100 (Prolgolimab) is a humanized monoclonal antibody targeting the PD-1 immune checkpoint. It is utilized in oncology research, particularly for melanoma, to investigate immune checkpoint blockade mechanisms in both in vitro cellular assays and in vivo preclinical models.
Product Specifications
Product Name Alternative
BCD100, BCD-100
Target
PD-1/PD-L1
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
9.54 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
146.28 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
SIPG914Bo01-01 10 µg
Recombinant Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5)
Sign In for Pricing
View Details SIPG914Bo01-02 50 µg
Recombinant Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5)
Sign In for Pricing
View Details SIPG914Bo01-03 200 µg
Recombinant Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5)
Sign In for Pricing
View Details SIPG914Bo01-04 1 mg
Recombinant Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5)
Sign In for Pricing
View Details